The Valley Desk

ArticleInternational journal of molecular sciencesPublished

FDA-Approved Drug Repurposing as p53 Mutants Rescue Candidates Using Structure-Based Virtual Screening and Molecular Simulations

Read the publication ↗ Open access copy ↗

Regional connection

Listed An author affiliation on the Europe PMC record names Lankenau Institute for Medical Research, with Main Line Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
International journal of molecular sciences
Published
Subject terms
Humans; Ligands; Drug Approval; Protein Binding; Mutation; United States Food and Drug Administration; United States; Tumor Suppressor Protein p53; Molecular Dynamics Simulation; Drug Repositioning; Molecular Docking Simulation; Allosteric modulation
PubMed ID
42589334
PubMed Central ID
PMC13466752
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal